MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash and cashequivalents$9,797K (4.11%↑ Y/Y)Prepaid expenses andother current assets$1,001K Total current assets$10,798K (-2.55%↓ Y/Y)Operating leaseright-of-use asset$3,484K (-15.25%↓ Y/Y)Property and equipment,net$236K (-45.37%↓ Y/Y)Total assets$14,519K (-7.07%↓ Y/Y)Total liabilities andstockholders' equity$14,519K (-7.07%↓ Y/Y)Total liabilities$8,478K (-6.84%↓ Y/Y)Total stockholders'equity$6,041K (-7.40%↓ Y/Y)Accumulated deficit-$288,264K (-10.79%↓ Y/Y)Total currentliabilities$5,188K (6.07%↑ Y/Y)Operating leaseliability, current portion$3,290K (-21.83%↓ Y/Y)Additional paid-in capital$294,191K (10.34%↑ Y/Y)Common stock 0.001 parvalue 500,000,000...$114K (15.15%↑ Y/Y)Accrued expenses andother current...$3,107K Accounts payable$1,162K Operating leaseliability, current portion$919K
Balance Sheet

Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Inc. (APVO)

source: myfinsight.com